Clinical Case Reports (Nov 2022)

IVIG for refractory dysphagia in Antisynthetase syndrome: A truth hard to swallow

  • Mais Alnoukari,
  • Oziel Garza De La Garza,
  • Karrar Al Gburi,
  • Niral Patel,
  • Henderson Lopez,
  • Muhammad Shamim,
  • Henry Kwang

DOI
https://doi.org/10.1002/ccr3.6569
Journal volume & issue
Vol. 10, no. 11
pp. n/a – n/a

Abstract

Read online

Abstract Refractory dysphasia could be the main symptom of Antisynthetase syndrome (ASS). IVIG may have a major impact in the successful treatment of dysphasia in patients with ASS. In our patient with ASS, IVIG treatment was an unreplaceable treatment option, and the patient regains her ability to swallow within 2 days.

Keywords